Raimund Jakesz
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 131 publications
Validation of the CTS5 in four prospective, multicenter, randomized ABCSG trials.
Journal: Breast (Edinburgh, Scotland)
Published: November 14, 2024
Correction: Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
Journal: Breast cancer research and treatment
Published: May 05, 2024
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
Journal: Breast cancer research and treatment
Published: January 23, 2023
Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer.
Journal: NEJM evidence
Published: December 01, 2022
Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 28, 2021
The iTOP trial: Comparing immediate techniques of oncoplastic surgery with conventional breast surgery in women with breast cancer - A prospective, controlled, single-center study.
Journal: International journal of surgery (London, England)
Published: December 21, 2021
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
Journal: The New England journal of medicine
Published: July 28, 2021
Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34.
Journal: British journal of cancer
Published: April 26, 2020
Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34).
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 04, 2020
Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and Colorectal Cancer Study Group 8A trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 05, 2019
Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: January 09, 2019
Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: October 15, 2018
Last Updated: 09/26/2026